Abstract
Toxicological studies onN-methyl-4-methoxynaphthalimide (MMNI), a water pollutant, were performed on mice for acute toxicity, and on rats for distribution and subacute toxicity. The mutagenicity of MMNI and its metabolites in bacteria was also investigated. Seven days of consecutive administration with MMNI to male rats caused accumulation of MMNI in the adipose tissue, large intestine, and liver. Small amounts of MMNI were detected in the kidneys, spleen, thymus, and serum, and the metabolites of MMNI (C-hydroxide and conjugate) were detected primarily in the serum and liver, although they were rapidly excreted from the body by urinary routes. The LD50 value in male mice by intraperitoneal administration of MMNI was 7,700 mg/kg. No growth retardation was found in rats orally administered for 21 days. Male rats fed on 30,000 ppm and female rats fed on 6,700 or 30,000 ppm of MMNI exhibited slight growth retardation after a 40-day feeding trial. Enlargement of rat livers was seen in the high dose groups (100 mg/day, 6,700 and 30,000 ppm), along with moderate histological changes in liver (such as fatty infiltration, focal necrosis, proliferation of endoplasmic reticulum, and Mallory's bodies). Histological changes were also detected in kidneys (vacuolation and numerous hyalin droplets in the tubules) and pancreas (vacuolation). In these groups, mean amounts of serum protein were elevated, and serum glutamic pyruvic transaminase (SGPT) activities were decreased. Atrophy of thymus was seen in 6,700 and 30,000 ppm group, but immunosuppressive effect was not observed. An increase in the amounts of liver cytochrome P-450 was found in the rats given 10 and 100 mg daily doses of MMNI for 21 days. There was no mutagenic activity of MMNI on theSalmonella typhimurium TA98 and TA 100 with or without S-9 mix, whereas its metabolites present in the urine of rats had slight mutagenic activity on TA100.
Similar content being viewed by others
References
Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalianmicrosome mutagenicity test. Mutation Res 31:346–364
Garvey JS, Cremer NE, Sussdorf DH (1977) Methods in immunology, 3rd edition, WA Benjamin, Reading, MA, pp 388–392
Gold H (1975) The chemistry of fluorescent whitening agents. In: Anliker R, Muller G (eds) Fluorescent whitening agents, Environmental quality and safety, Vol. 4. Georg Thieme Publishers, Stuttgart, 39 pp
Jerne NK, Nordin AA, Henry C (1963) The agar plaque technique for recognizing antibody producing cells, Cell-bound antibody. C. Wister Institute Press, Philadelphia, PA, 109 pp
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Therap 96:99–113
Miyajima T, Ugawa M, Nunoura M, Tanaka H, Adachi S (1981) Treatment of fluorescent whitening agent (N-methyl-4-methoxynaphthalimide) by activated sludge. Proc Osaka Prefectural Institute of Public Health, Edition of Public Health 19:99–106 (in Japanese)
Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes, 1. Evidence for its hemoprotein nature. J Biol Chem 239:2370–2378
Oppenheim JJ, Schecter B (1980) Lymphocyte transformation. In: Rose NR, Friedman H (eds) Manual of Clinical Immunology (2nd edition). American Society for Microbiology, Washington, DC, 233 pp
Plotz PH, Talal N, Asofsky R (1968) Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol 100:744
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Otake, T., Aburada, S., Nishimura, H. et al. Toxicity of N-methyl-4-methoxynaphthalimide, a fluorescent whitening agent. Arch. Environ. Contam. Toxicol. 16, 119–127 (1987). https://doi.org/10.1007/BF01055367
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01055367